S7
References S8
Table S1
Crystallographic data and structure refinement for [Au 4 ]PF 6 were prepared according to literature procedures.
1,2

Synthesis of N,N'-disubstituted cyclic thiourea ligand (TU)
This ligand was synthesized via compounds A and B depicted in the following scheme by modifications of the literature procedures. 
Glyoxal-bis(4-methoxyphenyl)imine (A)
. 3 To a solution of p-anisidine (12.3 g, 0.1 mol) in EtOH (50 ml) was added a mixture of 40% aqueous solution of glyoxal (7.3 g, 0.05 mol), EtOH (10 ml) and water (10 ml) at 25 °C. The mixture was stirred overnight. Upon addition of water (30 ml), a yellow solid precipitated, which was collected by filtration and dried in vacuo. Yield: 5.5 g (82%). 
N,N'-Bis(4-methoxyphenylamino)ethane dihydrochloride (B).
3, 4 A suspension of glyoxal-bis(4-methoxyphenyl)imine (1.34 g, 5 mmol) in a mixture of THF (30 ml) and MeOH (5 ml) was treated at 0 °C with sodium borohydride (0.76 g, 20 mmol). The mixture was stirred overnight at 25 °C and subsequently heated for 2 h under reflux. Upon addition of ice-water (30 ml) and 3 M HCl (30 ml), a white solid precipitated, which was collected by filtration and dried in vacuo. Yield: 1.2 g (88% 1,3-Bis(4-methoxyphenyl)imidazolidine-2-thione (TU). 4 To a solution of N,N'-bis(4-methoxyphenylamino)ethane (1.4 g, 5 mmol) in dry THF (40 ml) was added 1,1'-thiocarbonyl diimidazole (1.1 g, 6 mmol) at 25 °C. The mixture was stirred overnight and subsequently heated for 2 h under reflux. After addition of water and ethyl acetate, the organic layer was washed with dilute HCl and brine, dried and concentrated. The pure product was obtained through recrystallization from 95% EtOH. Yield: 1.1 g (70% [Ag I (TU) 2 ]OTf (2). TU (0.31 g, 1 mmol) was dissolved in EtOH (10 ml), and AgOTf (0.13 g, 0.5 mmol) was added under an argon atmosphere. The mixture was stirred at room temperature for 3 h, and subsequently filtered to remove the unreacted AgOTf. The filtrate was left standing overnight to give colourless crystals, which were collected and dried in vacuo. Yield: 82%. 
Cytotoxicity and apoptosis assays
Cell viability assays. Cells were seeded in a 96-well flat-bottomed microplate at 2 x 10 4 cells/well in 100 µl of MEM medium containing 10% fetal bovine serum and incubated for 24 h. Complexes 1-3 and cisplatin were dissolved in DMSO just before use. Serial dilution of each complex was added to each well with final concentration of DMSO ≤ 1%. The cells were exposed with the complexes for 72 h. 10 µl of (3-(4,5-dimethyl-2-thiazoyl)-2,5-diphenyltetrazolium bromide (MTT, 5 mg/mL) was added to each well and incubation was continued for 4 h. 100 µl of solubilization solution (10% SDS in 0.01 M HCl) was added to each well. The O.D. 550 nm was measured with a microplate reader.
Staining of apoptotic cells. HeLa cells were seeded in a 12-well microplate at 2 × 10 5 cells/well. After incubation overnight, the cells were treated with complexes 1-3 (10 µM) for 24 h, and were then stained with cell permeable DNA intercalating fluorescent dye Hoechst 33342 (10 µg/ml) and examined under fluorescence microscope.
Metal uptake by cells
HeLa cells were seeded in 12-well plate at 2 ×10 5 cells/well and incubated for 24 h. Complex 1, 2 or AgNO 3 was then added at 10 µM. After incubation for 2 h, the medium was removed and the cell monolayer was washed three times with phosphate buffered saline (PBS). The cells were then lysed in water and digested in 70% HNO 3 at 80 °C for 2 h. The digests were diluted with water to 10 ml for ICP-MS analysis.
Cellular activities of thiol-dependent redox enzymes
Preparation of cellular extracts. Cells were seeded at 2 × 10 5 /well in 6-well plates and incubated for 24 h. Complexes 1-3 (10 -9 to 10 -4 M) were serially diluted and added to the cells (final DMSO concentrations ≤ 1%). After incubation for 1 h, the cells were washed three times with PBS, and 100 µl of ice-cold lysis buffer (50 mM phosphate buffer, pH 7.4, 1 mM EDTA, 0.1% Triton-X 100) were added to the cell layer. Cell lysis was carried on ice for 5 min and the cell lysates were collected and stored at -80 o C or assayed immediately.
Thioredoxin reductase (TrxR). Cell lysates (10 µg proteins) were added to a buffer (100 µl) containing 100 mM potassium phosphate, pH 7.4, 1 mM EDTA and 0.2 mM NADPH. Reaction was initiated by adding 5,5'-dithiobis(2-nitrobenzoic acid) (DTNB, 3 mM final) and the TrxR activities were determined as increases in O.D. 412 nm in 10 min.
Glutathione peroxidase (GPx). Cell lysates (10 µg proteins) were added to a buffer (100 µl) containing 2 mM GSH, 1 U glutathione reductase, and 0.2 mM NADPH. Reaction was initiated by adding tert-butyl hydroperoxide (300 µM) and the NADPH oxidation was measured as decreases in O.D. 340 nm in 10 min. GPx activities were determined by subtracting the spontaneous NADPH oxidation in the absence of tert-butyl hydroperoxide.
Glutathione reductase (GR).
Cell lysates (10 µg proteins) were added to a mixture (100 µl) containing 100 mM phosphate, pH 7.4, 1 mM EDTA, 1 mM GSSG and 0.2 mM NADPH. Immediately, reaction was initiated by adding DTNB (3 mM final) and the increases in O.D. 412 nm were measured for 10 min. GR activities were determined by subtracting the increases in O.D. 412 nm in the absence of GSSG.
Kinetic analysis of tight-binding inhibition of TrxR
5
Determination of inhibitory constant (K i ) derived from residual activities of preformed enzyme-inhibitor complexes.
6,7 Recombinant rat TrxR1 (ICMO Corp, Sweden; 1 nM) was reduced with NADPH (0.2 mM) and then incubated with 1 (0.3-10 nM) for 30 min in a 100 mM potassium phosphate buffer, pH 7.4 and 1 mM EDTA. The residual activities (initial rates of increases in O.D. 412 nm ) were measured using 0.75, 1.5 or 3 mM DTNB. The data were fit into Eq. 1 using GraphPad Prism 3.0 software.
)/(2E t ) (1) Eq. 1 describes the rate law of tight-binding inhibition in which case the inhibitor concentration is substantially depleted owing to formation of enzyme-inhibitor complex. In this equation, v o is the observed velocity in the absence of inhibitor, v s is the steadystate velocity in the presence of inhibitor, E t is the total enzyme concentration, and I is the inhibitor concentration. The apparent inhibitory constant (K i ) so obtained was 0.67 nM. Average inhibitory constant (K i * ) was calculated to be 36 pM using Eq. 2, which takes into account of competitive inhibition of the enzyme with the substrate and a predetermined K m of 0.2 mM.
Determination of K i by progress curve analysis. 8,9 Complex 1 (3-100 nM) was added to a mixture containing NADPH (0.2 mM), TrxR1 (1 nM), DTNB (3 mM), 100 mM phosphate buffer, pH 7.4 and 1 mM EDTA. The progress curves were each fit into Eq. 3 using GraphPad Prism 3.0 software,
where P is the product concentration (increases in O.D. 412 nm ), v i and v f are the initial and final steady-state velocities, respectively, and k app is the apparent first-order rate constant for establishment of the final steady-state inhibition. A plot of the obtained k app against the inhibitor concentrations followed a hyperbolic function, indicative of a two-step, tight-binding inhibition mechanism:
where EI is the initial collision complex, which subsequently undergoes isomerization to the final slow dissociating enzyme-inhibitor complex (EI*), k 3 is the forward isomerization rate, and k 4 is the reverse isomerization rate. The k 3 , k 4 and the dissociation constant of the initial collision complex EI (Ki) were obtained by fitting the data to Eq. 4. k app = k 4 + k 3 I t (I t + K i (1+S/K m )) (4) where I t is the inhibitor concentration, S is the substrate (DTNB) concentration, and K m is the Michaelis-Menten constant for reduction of DTNB by TrxR. Accordingly, k 3 = 0.011 s -1 , k 4 = 0.00014 s -1 , and K i = 1.39 nM. The overall inhibitory constant K i * was determined to be 18 pM using Eq. 5.
Effects of NADPH reduction of TrxR inhibition by complexes 1 and 2. TrxR1 (1 nM) was incubated with or without NADPH (0.2 mM) in reaction buffer (100 mM phosphate, pH 7.4, 1 mM EDTA) for 5 min. Complexes 1 or 2 (1-100 nM) was added and allowed to incubate for 30 min. DTNB (3 mM) and NADPH (0.2 mM) were then added. The TrxR activities were determined as the increases in O.D. 412 nm over 10 min.
Probing the cysteine and selenocysteine residues of TrxR
10-12
NADPH-reduced TrxR1 (0.1 µM) was treated with 1 (4 µM) or DMSO vehicle (2 %) in reaction buffer (100 mM phosphate buffer, pH 7.4, 1 mM EDTA) at room temperature for 1 h. 1 µl of the reaction mixture was taken out and added to new tubes containing 19 µl of 100 µM BIAM (Invitrogen) buffered with 200 mM Tris-HCl, pH 6.5 and 8.5, respectively). The incubation was carried out at 37 o C for 30 min to alkylate the remaining free -SeH and -SH groups of the enzyme. 20 µl of the reaction mixtures were mixed with loading buffer and subjected to SDS-PAGE on a 7.5% gel. The separated proteins were transferred to nitrocellulose membrane and the BIAM labelled proteins were detected with horseradish peroxidase conjugated streptavidin and enhanced chemiluminescence detection.
Size exclusion chromatography and ICP-MS analysis (SEC-ICP-MS) of TrxR
NADPH-reduced TrxR1 (0.18 µM) was treated with 1 (4 µM) or DMSO vehicle (2%) in reaction buffer (100 mM phosphate buffer, pH 7.4, 1 mM EDTA) at room temperature for 1 h and then subjected to SEC-ICP-MS analysis. For tryspin digestion, the reaction mixtures were passed through ultrafiltration membrane filter with molecular weight cutoff of 10 kDa (PALL Nanosep) and washed two times with milli-Q H 2 O. The clean-up samples were reconstituted in 25 mM ammonium bicarbonate and digested with sequencing grade trypsin (Promega) (TrxR: trypsin = 10:1, 
